L. B. Silverman

2.6k total citations · 2 hit papers
25 papers, 2.0k citations indexed

About

L. B. Silverman is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, L. B. Silverman has authored 25 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in L. B. Silverman's work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (3 papers) and Virus-based gene therapy research (3 papers). L. B. Silverman is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (3 papers) and Virus-based gene therapy research (3 papers). L. B. Silverman collaborates with scholars based in United States, Netherlands and Belgium. L. B. Silverman's co-authors include Marilyn D. Resh, Geoffrey M. Cooper, S A Okenquist, Carlos B. Ríos, Nalin Pant, James R. Broach, Bruce J. Mayer, John Kuriyan, Hidesaburô Hanafusa and David Baltimore and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

L. B. Silverman

24 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01

2001 659 citations L. B. Silverman Blood profile →
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides

1992 551 citations Gabriel Waksman, Dorothea Kominos et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. B. Silverman United States	13	1.0k	726	502	370	318	25	2.0k
Alan R. P. Paterson Canada	28	1.1k 1.1×	426 0.6×	531 1.1×	136 0.4×	466 1.5×	60	2.4k
E.R. Giblett United States	11	1.6k 1.6×	171 0.2×	146 0.3×	120 0.3×	274 0.9×	21	2.4k
Eigil Kjeldsen Denmark	27	1.7k 1.7×	461 0.6×	127 0.3×	860 2.3×	670 2.1×	99	2.6k
D M Tidd United Kingdom	19	1.2k 1.2×	265 0.4×	70 0.1×	134 0.4×	155 0.5×	40	1.6k
A. R. P. Paterson Canada	28	1.1k 1.1×	229 0.3×	441 0.9×	106 0.3×	380 1.2×	74	2.1k
D B Wasson United States	22	1.2k 1.2×	324 0.4×	82 0.2×	124 0.3×	576 1.8×	39	2.2k
Gerald J. Mizejewski United States	27	1.3k 1.3×	158 0.2×	439 0.9×	82 0.2×	590 1.9×	120	2.6k
David A. Gell Australia	27	2.3k 2.3×	123 0.2×	194 0.4×	461 1.2×	600 1.9×	58	3.6k
Manjit Hanspal United States	23	540 0.5×	310 0.4×	190 0.4×	331 0.9×	73 0.2×	47	1.9k
Lucy M. Rose United States	18	689 0.7×	220 0.3×	44 0.1×	135 0.4×	182 0.6×	45	1.2k

Countries citing papers authored by L. B. Silverman

Since Specialization

Citations

This map shows the geographic impact of L. B. Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. B. Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. B. Silverman more than expected).

Fields of papers citing papers by L. B. Silverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. B. Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. B. Silverman. The network helps show where L. B. Silverman may publish in the future.

Co-authorship network of co-authors of L. B. Silverman

This figure shows the co-authorship network connecting the top 25 collaborators of L. B. Silverman. A scholar is included among the top collaborators of L. B. Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. B. Silverman. L. B. Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hunger, Stephen P., Vaskar Saha, Meenakshi Devidas, et al.. (2020). Final results of CA180-372/COG AALL1122 phase 2 trial of dasatinib and chemotherapy in pediatric patients with newly-diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (PH plus ALL). 3 indexed citations

Pieters, Rob, Martin Schrappe, Andrea Biondi, et al.. (2015). INTERNATIONAL COLLABORATIVE TREATMENT PROTOCOL FOR INFANTS UNDER ONE YEAR WITH ACUTE LYMPHOBLASTIC OR BIPHENOTYPIC LEUKEMIA.

Lipsitz, S., Jeff Kutok, Tracie L. Miller, et al.. (2011). Impact of HFE mutations on cardiac status in survivors of childhood high-risk ALL: Dana-Farber Cancer Institute Childhood ALL 05-159.. Journal of Clinical Oncology. 29(15_suppl). 9508–9508. 2 indexed citations

Lipsitz, S., Tracie L. Miller, Donna Neuberg, et al.. (2010). Late cardiac status in long-term survivors of childhood high-risk ALL 8 years after continuous or bolus infusion of doxorubicin: The DFCI Childhood ALL 91-01 randomized trial.. Journal of Clinical Oncology. 28(15_suppl). 9513–9513. 1 indexed citations

Hijiya, Nobuko, Paul S. Gaynon, Elly Barry, et al.. (2009). A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia. 23(12). 2259–2264. 59 indexed citations

Lipshultz, Steven E., Rebecca E. Scully, Stuart R. Lipsitz, et al.. (2009). Gender differences in long-term dexrazoxane cardioprotection in doxorubicin-treated children with acute lymphoblastic leukemia. Journal of Clinical Oncology. 27(15_suppl). 10005–10005. 1 indexed citations

Ohnuma, T, John Roboz, Jian‐Dong Jiang, et al.. (2006). Phase I study of ON 01910.Na by 3-day continuous infusion (CI) in patients (pts) with advanced cancer. Journal of Clinical Oncology. 24(18_suppl). 13137–13137. 11 indexed citations

Stone, Richard M., L. B. Silverman, Wendy Stock, et al.. (2006). A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias. Journal of Clinical Oncology. 24(18_suppl). 6585–6585. 172 indexed citations

Moorman, Anthony V., S Raimondi, C-H Pui, et al.. (2005). No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities. Leukemia. 19(4). 557–563. 15 indexed citations

10.

Miret, Juan J., et al.. (2002). Functional Expression of Heteromeric Calcitonin Gene-related Peptide and Adrenomedullin Receptors in Yeast. Journal of Biological Chemistry. 277(9). 6881–6887. 41 indexed citations

11.

Silverman, L. B.. (2001). Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 97(5). 1211–1218. 659 indexed citations breakdown →

12.

Campbell, Robert M., W. Chen, Yong Chen, et al.. (1999). Selective A1-adenosine receptor antagonists identified using yeast Saccharomyces cerevisiae functional assays. Bioorganic & Medicinal Chemistry Letters. 9(16). 2413–2418. 30 indexed citations

13.

Silverman, L. B., Robert A. A. Campbell, & James R. Broach. (1998). New assay technologies for high-throughput screening. Current Opinion in Chemical Biology. 2(3). 397–403. 117 indexed citations

14.

Waksman, Gabriel, Dorothea Kominos, Scott C. Robertson, et al.. (1992). Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature. 358(6388). 646–653. 551 indexed citations breakdown →

15.

Silverman, L. B., et al.. (1992). Binding of pp60^v-src to membranes: evidence for multiple membrane interactions. Biochemistry and Cell Biology. 70(10-11). 1187–1192. 4 indexed citations

16.

Silverman, L. B. & Marilyn D. Resh. (1992). Lysine residues form an integral component of a novel NH2-terminal membrane targeting motif for myristylated pp60v-src.. The Journal of Cell Biology. 119(2). 415–425. 79 indexed citations

17.

Silverman, L. B., Kevin Anderson, & Daniel F. Klessig. (1985). Synthesis of the Ad2+ND5-specified 42K protein is regulated posttranscriptionally in abortively infected monkey cells. Journal of Virology. 56(3). 814–820. 2 indexed citations

18.

Cooper, Geoffrey M., S A Okenquist, & L. B. Silverman. (1980). Transforming activity of DNA of chemically transformed and normal cells. Nature. 284(5755). 418–421. 193 indexed citations

19.

Cooper, Geoffrey M. & L. B. Silverman. (1978). Linkage of the endogenous avian leukosis virus genome of virus-producing chicken cells to inhibitory cellular DNA sequences. Cell. 15(2). 573–577. 42 indexed citations

20.

Samet, Philip, William H. Bernstein, L. B. Silverman, & Christine Krämer. (1963). INDICATOR DILUTION CURVES IN ATRIAL SEPTAL DEFECT. Heart. 25(2). 191–201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact